The age range for children who are eligible for emergency use authorizations (EUAs) for COVID immunizations has been increased by the Food and Drug Administration (FDA), and it has gone from five to six months for those children who are eligible.
Today, we amended the emergency use authorizations (EUAs) of the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 vaccines to include use in children down to 6 months of age. https://t.co/dHHwGFJ7fW pic.twitter.com/z4zZNwZZZ0
— U.S. FDA (@US_FDA) December 8, 2022
The declaration was delivered early on Thursday morning by Peter Marks, who is the top officer in charge of supervising the rules regarding vaccinations for the agency.
This comes after Pfizer and BioNTech made a proposal to the government on Monday, asking that the vaccine be allowed to be used in children who are less than five years old.
The Food and Drug Administration (FDA) now recommends that children get three doses of the COVID-19 immunisation. Reports indicate that they anticipate receiving the information they need to support a fourth dose by the end of the month of January.
BREAKING: With our partner @BioNTech_Group, we received EUA from the @US_FDA for our Omicron-adapted #COVID19 vaccine in children 6mos-4yrs. Doses to be shipped immediately upon recommendation by CDC. Learn more: https://t.co/RtTBrUjD0o pic.twitter.com/yhz8QX6j9X
— Pfizer Inc. (@pfizer) December 8, 2022
According to figures provided by the CDC, just 6.4% of children under the age of two have received at least one dose of a COVID immunization.
The preceding is a summary of an article that originally appeared on Oann.